Psoriasis Longitudinal Assessment and Registry (NCT00508547)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported assessment of psoriatic arthritis (PsA); and clinical and quality of life outcomes.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (3 items).
Location: Clinical Research Facility — Birmingham, Alabama
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Refuse to consent or are unwilling to respond to requests for long term information within the required time frame
- Are participating or have already planned to participate in a clinical trial with non-marketed investigational agents or are participating in a Janssen-sponsored clinical trial with marketed agents
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (320 Sites)
- Clinical Research Facility — Birmingham, Alabama
- Clinical Research Facility — Florence, Alabama
- Clinical Research Facility — Huntsville, Alabama
- Clinical Research Facility — Phoenix, Arizona
- Clinical Research Facility — Scottsdale, Arizona
- Clinical Research Facility — Tucson, Arizona
- Clinical Research Facility — Rogers, Arkansas
- Clinical Research Facility — Bakersfield, California
- Clinical Research Facility — Clovis, California
- Clinical Research Facility — Fountain Valley, California
- Clinical Research Facility — Fresno, California
- Clinical Research Facility — Loma Linda, California
- Clinical Research Facility — Los Angeles, California
- Clinical Research Facility — Mountain View, California
- Clinical Research Facility — Oxnard, California
- Clinical Research Facility — Redding, California
- Clinical Research Facility — Rolling Hills Estates, California
- Clinical Research Facility — San Diego, California
- Clinical Research Facility — San Ramon, California
- Clinical Research Facility — Santa Monica, California
- Clinical Research Facility — Sherman Oaks, California
- Clinical Research Facility — Upland, California
- Clinical Research Facility — Vallejo, California
- Clinical Research Facility — Colorado Springs, Colorado
- Clinical Research Facility — Englewood, Colorado
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.